Principal Investigator Peter Gasser MD has enrolled 4 patients in his Swiss LSD/end-of-life anxiety study. On November 3, the second of the patients had an LSD session. On Friday, November 7, MAPS transferred $25,000 to the Swiss bank account of the Swiss Medical Association for Psycholytic Therapy (SAEPT), with the funds restricted to the Swiss LSD end-of-life anxiety study. We would like to thank Robert Barnhart for his continued and generous support for this research.
The study’s budget is $225,000, we have already raised about $125,000. We are still seeking the final donations of $100,000.